Participants
neurological disorders
NEUROLOGICAL DISORDERS
96 healthy volunteers (age 19–43; 50 women) participated in this study. The participants were recruited during 2019–2021. None of the subjects had any past or present neurological disorders or pharmacological treatment on the day of the experiment. All participants provided written informed consent before the experimental intervention. The study was conducted in accordance with the Declaration of Helsinki and the Spanish National Research Council (CSIC) Ethics Committee approved all the procedures (ref 201850E062; 024/2019). At the beginning of the session, the subjects completed a questionnaire to collect demographic data such as Regarding the confidentiality of the collected data, each participant was assigned a unique code, along with their personal sociodemographic data, informed consent, and an opinion survey. These files remained in custody of the project administrator (corresponding author), while the number assigned to the subject was the label of the data that was later analyzed. Thus, there was no possibility of relating the records to the participants from whom they were obtained. The coded data were stored in our laboratory hard drives.